ConductScience.org, home

Paper68278

Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease.

Davies TF and 5 others. Lancet, 1977. Cited by 144 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Papers, record 68278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68278

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
144
iCite
Relative citation ratio, by iCite
5.12
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davies TFT F
2Yeo PPP P
3Evered DCD C
4Clark FF
5Smith BRB R
6Hall RR

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Graves DiseaseMajor topic
Thyroid GlandMajor topic
Adult
Antithyroid Agents
Female
Humans
Prognosis
Recurrence

Source PubMed

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.

PMIDTitleJournalYearIn PapersSource
40,622,195The evolving therapeutic landscape of Graves' disease in adults: present and future.Eur Thyroid J2025https://conductscience.org/library/papers/40622195PubMed
37,876,493Methimazole, an Effective Neutralizing Agent of the Sulfur Mustard Derivative 2-Chloroethyl Ethyl Sulfide.ACS Bio Med Chem Au2023https://conductscience.org/library/papers/37876493PubMed
37,627,966Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA).Diagnostics (Basel)2023https://conductscience.org/library/papers/37627966PubMed
36,514,581Utility of Antibodies in the Diagnoses of Thyroid Diseases: A Review Article.Cureus2022https://conductscience.org/library/papers/36514581PubMed
36,129,5922021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.Endocrine2023https://conductscience.org/library/papers/36129592PubMed
29,456,513Stochastic Effects in Autoimmune Dynamics.Front Physiol2018https://conductscience.org/library/papers/29456513PubMed
23,539,719Clinical review: Clinical utility of TSH receptor antibodies.J Clin Endocrinol Metab2013https://conductscience.org/library/papers/23539719PubMed
6,896,520Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.J Endocrinol Invest1982https://conductscience.org/library/papers/6896520PubMed
6,699,171Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo.J Clin Invest1984https://conductscience.org/library/papers/6699171PubMed
6,147,37710 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).J Endocrinol Invest1984https://conductscience.org/library/papers/6147377PubMed
6,139,399
The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
J Endocrinol Invest1983https://conductscience.org/library/papers/6139399PubMed
6,138,364
Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
J Clin Invest1983https://conductscience.org/library/papers/6138364PubMed
2,900,851Measurement of TSAb directly in serum using FRTL-5 cells.J Endocrinol Invest1988https://conductscience.org/library/papers/2900851PubMed
2,573,625Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.J Endocrinol Invest1989https://conductscience.org/library/papers/2573625PubMed
2,422,245Changes in thyrotropin binding inhibiting immunoglobulins (TBII) in sera of patients with Graves' disease at the time of relapse or exacerbation.J Endocrinol Invest1986https://conductscience.org/library/papers/2422245PubMed
2,421,862Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.CMAJ1986https://conductscience.org/library/papers/2421862PubMed
1,283,984Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.J Endocrinol Invest1992https://conductscience.org/library/papers/1283984PubMed
582,828Interference of thyroglobulin in TSab detection by radio-receptor assay.J Endocrinol Invest1979https://conductscience.org/library/papers/582828PubMed
227,717TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.Experientia1979https://conductscience.org/library/papers/227717PubMed
90,689Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?J Endocrinol Invest1978https://conductscience.org/library/papers/90689PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/68278

GET https://conductscience.org/api/papers/v1/68278/cited_by?page=2